Henry Meds

The annual discount asks you to decide early

Henry Meds has a clear attraction: one payment arrangement combines provider access, medication and ongoing care. Its FAQ says shipping and applicable supplies are included too. For a patient comfortable paying cash, that can make budgeting simpler than arranging several separate services. The complication is that Henry sells both monthly access and discounted longer commitments, which expose different amounts of money if the arrangement does not suit you.

The public programs page lists injectable semaglutide at $297 monthly. Its six-month paid-in-full amount is $1,482, equivalent to $247 monthly, and the twelve-month prepaid amount is $2,364, equivalent to $197. The lowest equivalent requires buying the year. It is not a $197 cancel-anytime monthly charge.

My starting recommendation is the ordinary monthly option for someone new to the service, even though its displayed rate is higher. After understanding the clinician relationship, prescription and fulfillment, a longer term becomes easier to evaluate. The difference in headline rate should compensate you for surrendering flexibility; it should not be the reason to ignore that flexibility.

Count charges and shipments separately

The programs page describes injectable semaglutide supply and delivery schedules alongside the price. The monthly section uses different amounts and intervals from the prepaid packages, which describe shipments every sixty days. A billing month therefore should not be treated as a promise of a new shipment every month or a particular number of vials.

Ask for a schedule showing charge dates, expected dispensing dates, medication quantity and the period each shipment is intended to cover. If you are transferring from another clinic, include your current prescription and remaining supply in the discussion. Do not assume a different program will continue the exact dose without review.

The FAQ estimates eight to ten business days after the provider interaction for most deliveries and warns of longer California fulfillment. That is a useful planning allowance rather than a guaranteed arrival date. I would avoid timing a transfer around the fastest possible dispatch, especially if a delay would leave a gap in care.

Canceling an account may leave a balance

Henry’s FAQ allows cancellation in the portal, by email or by phone, but says a multi-month balance may remain payable unless a clinician determines you cannot continue for medical reasons. Its separate Subscribe to Save terms likewise retain the remaining commitment payments after an ordinary mid-term cancellation. Check whether that agreement applies to your selected enrollment.

The refund policy makes subscription fees generally nonrefundable. Its medical-discontinuation exception requires documentation from a licensed professional and review by Henry’s clinical team; medication already dispensed is excluded. This is a specific exception, not a general right to recover unused money whenever you decide to stop.

There can also be deductions. The policy describes a nonrefundable $30 consultation component when an evaluation produces a prescription, plus a possible processing fee. Ask for an example using the exact plan you are considering: if treatment ends after one shipment, what remains payable and what, if anything, can be refunded? A dollar answer is more useful than cancel-anytime language.

The oral catalog needs a precise order summary

Henry’s programs page lists compounded sublingual semaglutide and oral tirzepatide separately from injectable semaglutide. Some oral headings and their supply descriptions conflict: a tirzepatide three-month heading is followed by language describing six months, and a semaglutide heading repeats tirzepatide wording. I would not resolve those discrepancies by guessing what a patient receives.

If you want a needle-free route, request the ingredient, dosage form, frequency, quantity, total price and delivery interval in one written explanation. A price for a compounded dissolving tablet is not an injectable quote. Equally, evidence about an approved formulation cannot establish the effectiveness of a different compounded tablet.

FDA recommends compounded GLP-1 medication only when an approved drug cannot meet a patient’s medical needs. These preparations have not undergone FDA premarket review for safety, effectiveness and quality. The clinician should explain the medical reason for the selected preparation and the evidence supporting its route. That discussion belongs before the purchase decision.

Evaluate the clinician relationship before the long term

Henry says the initial review may be a video visit or an independent review without video, depending on the state. Secure portal messaging is available. The medical consent distinguishes the technology company from the independent professional entity providing medical care. Ask which practice and clinician will handle your case, rather than treating the platform name as the prescriber’s identity.

An ongoing-care bundle needs an ongoing-care plan. Ask how follow-ups are scheduled, when testing is appropriate, who reviews treatment concerns and how to request a medication change. The public material I checked did not establish a universal clinician response deadline or a patient-specific lab charge. Those gaps should be resolved for your own plan.

The programs page describes appropriately licensed compounding pharmacies but does not establish the pharmacy assigned to your prescription. Obtain its name and contact details and check dispensing eligibility in your state. This review did not independently verify an assigned clinician, pharmacy license or medication batch.

Report delivery problems while the evidence is available

Henry’s refund and replacement policy provides a remedy for verified dispensing errors and sets conditions for other problems. Keep the packaging, label and shipment details, and report a concern promptly through the designated channel. A replacement process is different from a change-of-mind refund; the policy treats dispensed and shipped prescription medication as final sale.

I would shortlist Henry for a patient who understands the compounded preparation, wants the bundled care arrangement and accepts the selected payment obligation. I would postpone annual prepayment until the service has earned that confidence. This judgment reflects public offers and policies checked October 25, 2026, with no enrollment, treatment, dispensing test or direct support interaction.